| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/30/2006 | WO2005116028A3 Bicyclic heterocycles as kinase inhibitors |
| 03/30/2006 | WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 03/30/2006 | WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 03/30/2006 | WO2005044793A3 Nitrogen-containing fused heterocyclic compounds |
| 03/30/2006 | WO2005040169A3 Fused heterocyclic compounds as serotonin receptor modulators |
| 03/30/2006 | US20060069258 Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 03/30/2006 | US20060069119 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 03/30/2006 | US20060069118 Crystalline forms of a factor Xa inhibitor |
| 03/30/2006 | US20060069117 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/30/2006 | US20060069116 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/30/2006 | US20060069111 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome |
| 03/30/2006 | US20060069109 Therapeutic agents |
| 03/30/2006 | US20060069106 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060069089 Fungicides |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | CA2581150A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | CA2580777A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 03/30/2006 | CA2580749A1 Quinolone analogs |
| 03/30/2006 | CA2579406A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as protein kinase inhibitors |
| 03/30/2006 | CA2574220A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
| 03/29/2006 | EP1638973A1 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| 03/29/2006 | EP1638971A1 Preparation of substituted quinoxalines from the dianiline with 2,3-dihydroxy-1,4-dioxane |
| 03/29/2006 | EP1638970A1 Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors |
| 03/29/2006 | EP1638969A2 Cgrp receptor antagonists |
| 03/29/2006 | EP1638968A1 Hexahydropyridoisoqinolines as dpp-iv inhibitors |
| 03/29/2006 | EP1638967A2 Cycloalkanepyrrolopyridines as dp receptor antagonists |
| 03/29/2006 | EP1638966A2 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO ¬3,4-d| PYRIMIDINE AND PYRROLO ¬2,3-d| PYRIMIDINE AND USES THEREOF |
| 03/29/2006 | EP1638954A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors |
| 03/29/2006 | EP1638945A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/29/2006 | EP1638935A1 Nk1 antagonist |
| 03/29/2006 | EP1638578A2 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 03/29/2006 | EP1638568A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 03/29/2006 | EP1638566A2 Sulfonamide substituted imidazoquinolines |
| 03/29/2006 | CN1753996A The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 03/29/2006 | CN1753900A Inhibitors |
| 03/29/2006 | CN1753894A Pyrazolopyridine derivates |
| 03/29/2006 | CN1753893A The enantiomer of tenatoprazole and the use thereof in therapy |
| 03/29/2006 | CN1753892A Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors |
| 03/29/2006 | CN1753671A 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247587C Tert. alkylphenoxy substituted polycyclic compounds |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019142 Process for preparing naphthyridones and intermediates |
| 03/28/2006 | US7019140 Reduction and demethylation of quaternary ammonium salts with nucleophiles, e.g., an alkyl- or toluenesulfonyl halide, of an intemediate from 9,10-dihydrolysergic acid; followed by reacting with a sodium thiomethoxide; purity; efficiency; nontoxic; by-product inhibition |
| 03/28/2006 | US7019094 Intermediate products, methods for their preparation and use thereof |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019002 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents |
| 03/28/2006 | US7019001 Substituted benzothiazole amide derivatives |
| 03/28/2006 | US7018620 Delivery of beta-blockers through an inhalation route |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/23/2006 | WO2006031959A1 Process for the preparation of 6, 8-substituted `1, 7 naphthpyridin derivatives by reacting the 8-halo-`1, 7 naphthpyridin-derivate with an organic boronic acid derivatives and intermadiates of this process |
| 03/23/2006 | WO2006029980A1 Substituted bicyclic imidazo-3-ylamine compounds |
| 03/23/2006 | WO2006004884A3 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 03/23/2006 | WO2005118584A3 Saframycin analogs as therapeutic agents in the treatment of cancer |
| 03/23/2006 | WO2005048945A3 Hydroxylamine substituted imidazo ring compounds |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/23/2006 | US20060063797 Process for preparing a substituted imidazopyridine compound |
| 03/23/2006 | US20060063796 Pyrazoles as inhibitors of tumor necrosis factor |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063761 Novel benzothiazole compounds and methods of use thereof |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060062932 has optical properties with films that are significantly thinner |
| 03/23/2006 | DE19638886B4 Selektive Herbizide auf Basis von Metribuzin und substituierten Imidazo [1,2-a]pyridin-3-yl-sulfonylverbindungen Selective herbicides based on metribuzin and substituted imidazo [1,2-a] pyridin-3-yl-sulfonyl |
| 03/23/2006 | DE112004000832T5 Lichtemittierende Polymerzusammensetzung Light-emitting polymer composition |
| 03/23/2006 | CA2580343A1 Imidazoquinoline compounds |
| 03/23/2006 | CA2580251A1 Substituted bicyclic imidazo-3-yl-amine compounds |
| 03/23/2006 | CA2580135A1 7-azaindoles and their use as ppar agonists |
| 03/23/2006 | CA2579717A1 Tricyclic anilide spirolactam cgrp receptor antagonists |
| 03/23/2006 | CA2577171A1 Process for the preparation of 6, 8-substituted `1, 7 naphthpyridin derivatives by reacting the 8-halo-`1, 7 naphthpyridin-derivate with an organic boronic acid derivatives and intermadiates of this process |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1636228A1 Novel pyridopyrazines and use thereof as kinase modulators |
| 03/22/2006 | EP1636227A1 Pyrimidine derivatives possessing cell-cycle inhibitory activity |
| 03/22/2006 | EP1636226A1 AZAINDOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1636225A2 Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents |
| 03/22/2006 | EP1636224A2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 03/22/2006 | EP1636218A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/22/2006 | EP1636217A1 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 03/22/2006 | EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1636208A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 03/22/2006 | EP1636195A1 Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors |
| 03/22/2006 | EP1635846A2 Small molecule toll-like receptor (tlr) antagonists |
| 03/22/2006 | EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 03/22/2006 | EP1549650B1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 03/22/2006 | EP1244660B1 Methods and compositions for the treatment of pain |
| 03/22/2006 | EP1200433B1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | CN1751052A Therapeutic agents |
| 03/22/2006 | CN1751050A Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 03/22/2006 | CN1751043A Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors |
| 03/22/2006 | CN1751042A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/22/2006 | CN1751041A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |